☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Passage Bio
Dr. Samiah Al-Zaidy, VP of Clinical Development at Passage Bio Shares Insights on Additional Interim Data from the Imagine-1 Study...
May 22, 2023
Passage Bio Reports the First Patient Dosing of PBKR03 in the P-I/II (GALax-C) Trial for the Treatment of Infantile Krabbe Disease
March 11, 2022
PharmaShots Weekly Snapshots (April 05 - 09, 2021)
April 9, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
